GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » China Healthwise Holdings Ltd (HKSE:00348) » Definitions » Capex-to-Revenue

China Healthwise Holdings (HKSE:00348) Capex-to-Revenue : 0.00 (As of Dec. 2023)


View and export this data going back to 1997. Start your Free Trial

What is China Healthwise Holdings Capex-to-Revenue?

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

China Healthwise Holdings's Capital Expenditure for the six months ended in Dec. 2023 was HK$0.00 Mil. Its Revenue for the six months ended in Dec. 2023 was HK$65.49 Mil.

Hence, China Healthwise Holdings's Capex-to-Revenue for the six months ended in Dec. 2023 was 0.00.


China Healthwise Holdings Capex-to-Revenue Historical Data

The historical data trend for China Healthwise Holdings's Capex-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China Healthwise Holdings Capex-to-Revenue Chart

China Healthwise Holdings Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Dec20 Dec21 Dec22 Dec23
Capex-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.02 0.03 - - -

China Healthwise Holdings Semi-Annual Data
Mar14 Sep14 Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Capex-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of China Healthwise Holdings's Capex-to-Revenue

For the Pharmaceutical Retailers subindustry, China Healthwise Holdings's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


China Healthwise Holdings's Capex-to-Revenue Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, China Healthwise Holdings's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where China Healthwise Holdings's Capex-to-Revenue falls into.



China Healthwise Holdings Capex-to-Revenue Calculation

China Healthwise Holdings's Capex-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-0.191) / 146.317
=0.00

China Healthwise Holdings's Capex-to-Revenue for the quarter that ended in Dec. 2023 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (0) / 65.491
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


China Healthwise Holdings  (HKSE:00348) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.


China Healthwise Holdings Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of China Healthwise Holdings's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


China Healthwise Holdings (HKSE:00348) Business Description

Traded in Other Exchanges
N/A
Address
168-200 Connaught Road Central, Unit 1209, Shun Tak Centre, West Tower, Hong Kong, HKG
China Healthwise Holdings Ltd is an investment holding company. It operates in three segments: Chinese health products, Money lending business, and investment in financial instruments. The majority of its revenue comes from trading in Chinese health products, which include pharmaceutical products, ginseng, and dried seafood products. The company's geographical segments are Hong Kong and the PRC, of which key revenue is derived from Hong Kong.
Executives
Eternity Investment Limited 2201 Interest of corporation controlled by you
Heng Tai Consumables Group Limited 2201 Interest of corporation controlled by you
Heng Tai Finance Limited 2101 Beneficial owner
Lei Hong Wai 2101 Beneficial owner

China Healthwise Holdings (HKSE:00348) Headlines

No Headlines